News | September 09, 2007

Preclinical Researchers Take A 'New Point Of View'

September 10, 2007 - For the fourth year in a row, Siemens Medical Solutions, Molecular Imaging Division presented the Preclinical Image of the Year Awards this weekend at the Siemens Preclinical User's Group Meeting, held in Providence, R.I.

The competitive awards are the company's way of honoring pioneering researchers and their contributions. This year's entries demonstrated how advanced preclinical imaging solutions may shed new light on disease processes and potential treatment pathways. Images were acquired on Siemens Medical Solutions preclinical imaging systems: the multimodality Inveon preclinical scanner and the microPET (positron emission tomography) and microCAT (computed axial tomography) scanners, which have been long-time industry leaders.

Preclinical PET Image of the Year:
"In vivo FDG-PET imaging of glucose uptake in pressure overloaded mice to evaluate metabolic mechanism and cardiac function during myocardial hypertrophy," Acquired by Bijoy K. Kundu, Stuart S. Berr, G. Paul Matherne and Amy R. Lankford from the University of Virginia.

Preclinical CT Image of the Year:
"Imaging and analysis for the assessment of the normal mouse lung," acquired by Eric A. Hoffman, Geoffrey McLennan, Joseph M. Reinhardt, Gary E. Christensen, Deokiee Chon, Eman Namati, Jacqueline Namati, Lijun Shi, Joo Hyun Song, Kunlin Cao and Jered Sieren from the University of Iowa.

Preclinical Multimodality Image of the Year:
"Adenovirus validation in lymph node metastasis," acquired by J. Burton, M. Johnson, D. Stout and L Wu from the University of California, Los Angeles, Crump Institute for Molecular Imaging.

Most Innovative Preclinical Image of the Year:
"Micro-array or MicroPET?" acquired by K. Gagnon and J. Sutcliffe from the University of California, Davis.

For more information: www.usa.siemens.com/medical

Related Content

PET Imaging Agent Predicts Brain Tau Pathology, Alzheimer's Diagnosis
News | PET Imaging | September 05, 2018
Eli Lilly and Co. and Avid Radiopharmaceuticals Inc. announced a Phase 3 study of positron emission tomography (PET)...
Abnormal Protein Concentrations Found in Brains of Military Personnel With Suspected CTE

Researchers are using the tracer, which is injected into a patient, then seen with a PET scan, to see if it is possible to diagnose chronic traumatic encephalopathy in living patients. In this image, warmer colors indicate a higher concentration of the tracer, which binds to abnormal proteins in the brain. Credit UCLA Health.

News | PET Imaging | August 24, 2018
August 24, 2018 — In a small study of
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
Novel PET Imaging Method Could Track and Guide Type 1 Diabetes Therapy
News | PET Imaging | August 03, 2018
Researchers have discovered a new nuclear medicine test that could improve care of patients with type 1 diabetes. The...
Researchers Trace Parkinson’s Damage in the Heart
News | PET Imaging | July 17, 2018
A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new therapies and...
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
SNMMI Image of the Year Highlights Theranostic Approach for Advanced Prostate Cancer

IMAGE OF THE YEAR: PSMA PET before and after lutetium-177 PSMA617 theranostics in 8 patients with metastatic prostate cancer who exhausted standard therapeutic options.

68Ga-PSMA11 PET maximum intensity projection (MIP) images at baseline and 3 months after 177Lu-PSMA617 in 8 patients with PSA decline ≥ 98 percent in a prospective phase II study. Any disease with SUV over 3 is in red. Credit: Michael Hofman, John Violet, Shahneen Sandhu, Justin Ferdinandus, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, Sue Ping Thang, Price Jackson, Mark Scalzo, Scott Williams and Rodney Hicks, Peter MacCallum Cancer Centre, Melbourne, Australia.

News | PET Imaging | June 29, 2018
In the battle against metastatic castrate-resistant prostate cancer, studies have demonstrated a high response rate to...
MILabs Introduces Futuristic PET Capabilities on New VECTor6 System
Technology | PET Imaging | June 28, 2018
At the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, June 23-26, in Philadelphia,...
Philips North America and GE Healthcare Win IMV PET Imaging ServiceTrak Awards
News | PET Imaging | June 25, 2018
IMV, part of the Science and Medicine Group and a market research and business intelligence provider to the imaging...
FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems
Technology | PET-CT | June 21, 2018
Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for...